Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check7 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2; the study page remains an error page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the expected study record content, with the header and footer still visible. This indicates restricted access or an unavailable page rather than updated trial information.SummaryDifference19%

- Check56 days agoChange DetectedRevision: v3.6.6 was applied, replacing v3.6.5. This indicates a site update rather than changes to the study details or general page content.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation. No core study content or participant-facing information is affected.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a new version of the page deployment. This appears to be a minor technical update rather than a change to the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.